Market capitalisation
?
Share price multiplied by shares outstanding. It does not measure company cash.
Company analysis·LLY
Preparing the analysis
We’re preparing the company’s analysis.
NYSE·LLY
Eli Lilly and Company
Share price$1,354.00Price as of: Nov 6, 2026
Eli Lilly and Company (LLY) is a company listed on NYSE, classified under Drug Manufacturers - General.
Eli Lilly is a global pharmaceutical company focused on diabetes, oncology, autoimmune, and neuroscience treatments.
Revenue · FY 2025
?
Sales generated during the period, before costs and expenses.
Net margin · FY 2025
?
Net income as a proportion of revenue.
“Our take” and other explanations are generated with artificial intelligence from the data, without human review of each text. They are descriptive, not recommendations. Learn more
Explore questions
P1 · What does it do and how does it make money?
Of every $100 it takes in,94 come from Product.
Product is its largest source of revenue (93.5%), followed by Collaboration and Other Revenue (6.5%). Here you will see what it sells, where, and how that mix is changing.
$65bnrevenue in FY 2025
2business lines with data
67%of sales, in UNITED STATES
Full fiscal year ended Dec 31, 2025
After that close
Q3 2026, ended Sep 30, 2026: total revenue +38.6% against the same quarter a year earlier.
This is the revenue of the whole company. The split by lines and regions on this page is still that of the full fiscal year.01How it makes money
The data does not separate products from services.
Not all revenue behaves the same way. A one-off sale depends on someone buying again; a service is billed again and again while the customer stays.
Its business lines · FY 2025
02Where revenue comes from
A single line brings in half or more.
Each rectangle is a business line and its size is the share of revenue it brings in. Select one to see the detail.
No room for a label in the mosaic
Area = share of total revenue for the year. It does not show profit: the company does not report what each line earns.
What is a segment's weight?
The part of everything the company takes in that comes from that line. If a line weighs 49%, then of every 100 in sales, 49 come from it.
How to read it
The more a line weighs, the more revenue depends on it. A high weight is neither good nor bad by itself: it shows where to look first.
03Where sales come from
It depends on one main market.
UNITED STATES is its largest market, with 66.7% of sales. Each square is a region and its area is what it sells there.
Regions from largest to smallest · FY 2025
04How the mix is changing
Product is gaining weight.
Weight of each part in 2024 and in 2025. A line gains weight when it grows faster than the total.
FY 2024FY 2025
pp = percentage points: the difference between two percentages (from 25% to 27% is 2 pp).
05Read with care
What we can deduce from the data. And what we cannot.
We can deduceWe cannot conclude
01
Concentration in Product increased: by FY 2025 it dominates almost everything and the other lines weigh even less.
That Collaboration and Other Revenue could offset a fall in Product: it dropped in FY 2025 and does not provide stability.
02
While the US remains dominant (66.7%), Europe drove relative growth in FY 2025: it brought 23.0% of the increase despite being just 15.4% by weight.
That Europe is on track to become the largest region: it still lags far behind the US in total sales.
Our take
Growth and business weight now fully depend on Product, with the role of other lines and regions shrinking further.
- 01Shown by the figures
Product is the single engine for the company
In FY 2025, Product held 93.5% of revenue and generated all growth, offsetting even the drop in Collaboration and Other Revenue. All expansion capability came from this line, with no counterweight from others.
- 02Shown by the figures
Europe drives growth more than its weight
While Europe makes up only 17.7% of sales, it delivered 23.0% of the increase, growing well above average, but its base remains far behind the US.
- 03Our interpretation
Limited diversification and rising reliance
Diversification diminished: Collaboration and Other Revenue fell and contributed negatively, so the company increasingly leans on a single business driver.
What is not proven
It is unknown how much profit or margin relies on Product versus smaller, shrinking lines. If Product’s growth slowed, could the business sustain profitability with the rest?
See the calculations behind it
- Dependence on Product rises: from 90.5% of revenue in FY 2024 to 93.5% in FY 2025.
- Product brought $20.2B of the $20.1B by which revenue grew in FY 2025 (100.4%), although it weighed 90.5%. Without that line, the rest grew −1.7%.
- Collaboration and Other Revenue took away $73.8M in FY 2025; the other lines made up for it and revenue still rose $20.1B.
- United States brings 66.7% of sales (67.4% in FY 2024). The fastest-growing region is Europe: +67.0% against +44.7% overall.
- Product brought $20.2B, more than the whole increase in revenue in FY 2025 ($20.1B).
- Product weighs more than all the other lines together: 93.5% of revenue in FY 2025.
With data to Nov 4, 2026. Analysis written by a language model from our calculations, which supply every figure. It is not investment advice.
Next step